Waist circumference is a better predictor than body mass index of insulin resistance in type 2 diabetes

International Journal of Diabetes and Metabolism

Volumn 19, Issue 1, 2011, Pages 35-40

  Liao, Ying Li ^a   Lin, Su Ching ^c   Hsu, Chung Hua ^b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c TAIPEI HOSPITAL   (Taiwan)

Author keywords

Body mass index; Insulin resistance; Type 2 diabetes; Waist circumference

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; CHINESE; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; WAIST CIRCUMFERENCE;

EID: 80051637580     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med 2001; 344:1343-1350.
2. Lawlor DA, Davey Smith G, Ebrahim S. Life course influences on insulin resistance: findings from the British women's heart and health study. Diabetes Care 2003; 26: 97-103.
3. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-1935.
4. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independenct and opposite effects on cardiovascular disease risk factors:the Quebec Family Study. Am J Clin Nutr 2001; 74:315-321.
5. Han TS, van Leer EM, Scidell JC, Lean ME. Waist circumference action levels in the identification cardiovascular disease risk factors: prevalence study in a random sample. BMJ 1995; 311; 1401-1405.
6. McLaughlin T, Abbasi E, Chcal K, Chu J, Lamendola G, Reven G. Use of metabolic markersto identify overweight individuals who are insulin resistance. Ann Intern Med 2003;139: 802-809.
7. Thomas GN, Ho SY, Lam KS, Janus ED, Hedley AJ, Lam TH. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obesity Research 2004;12: 1905-1812.
8. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care 2006; 29: 673-678.
9. Kohrt WM, Kirwan JP, Statern MA, Bourey RE, King DS, Holloszy JO. Insulin resistance in aging is related to abdominal obesity. Diabetes 1993;42:273-281.
10. Reeder BA, Senthilselvan A, Despres JP, Angel A, Liu L, Wang H, Rabkin SW. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ 1997; 157 (Suppl1):39-45.
11. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay, Nadeau A, Lupien PJ. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexs of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-468.
12. Lear SA. Waist circumference is simpler than body mass index (letter). Clin Chem 2005;51: 1082-1083.
13. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
14. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M. HOMA-Estimated Insulin resistance is an independent predictor of cardiovascular disease in Type 2 diabetic subjects: prospective data from the Verona diabetes complications study. Diabetes Care 2002; 25: 1135-1141.
15. World Health Organization. The Asia-Pacific persperctive: redefinding obesity and it treatment. Melbourne, Australia: Health Communication; 2000:1-56.
16. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med 2001; 344:1343-1350.
17. Lawlor DA, Davey Smith G, Ebrahim S. Life course influences on insulin resistance: findings from the British women's heart and health study. Diabetes Care 2003;26: 97-103.
18. Singhal A, Jamieson N, Fewtrell M, Deanfield J, Lucas A, Sattar N. Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. J Clin Endocrinol Metab 2005;90:4615-4521.
19. Fernandez-Real JM, Castro A, Vazquez G, Casamitjana R, Lopez-Bermejo A, Penarroja G, Ricart W. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care. 2004;27:739-745.
20. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-1935.
21. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291:1730-1737.
22. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005;54:534-539.
23. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y. Circulating concentrationsof the adipocyte protein adiponectin are decrease in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50:1126-1133.
24. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective studies. BMJ; 2005; 330:1363-1364.
25. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003; 107:1626-1631.